| Literature DB >> 22645183 |
Liran I Shlush1, Noa Chapal-Ilani, Rivka Adar, Neta Pery, Yosef Maruvka, Adam Spiro, Roni Shouval, Jacob M Rowe, Maty Tzukerman, Dani Bercovich, Shai Izraeli, Guido Marcucci, Clara D Bloomfield, Tsila Zuckerman, Karl Skorecki, Ehud Shapiro.
Abstract
Human cancers display substantial intratumoral genetic heterogeneity, which facilitates tumor survival under changing microenvironmental conditions. Tumor substructure and its effect on disease progression and relapse are incompletely understood. In the present study, a high-throughput method that uses neutral somatic mutations accumulated in individual cells to reconstruct cell lineage trees was applied to hundreds of cells of human acute leukemia harvested from multiple patients at diagnosis and at relapse. The reconstructed cell lineage trees of patients with acute myeloid leukemia showed that leukemia cells at relapse were shallow (divide rarely) compared with cells at diagnosis and were closely related to their stem cell subpopulation, implying that in these instances relapse might have originated from rarely dividing stem cells. In contrast, among patients with acute lymphoid leukemia, no differences in cell depth were observed between diagnosis and relapse. In one case of chronic myeloid leukemia, at blast crisis, most of the cells at relapse were mismatch-repair deficient. In almost all leukemia cases, > 1 lineage was observed at relapse, indicating that diverse mechanisms can promote relapse in the same patient. In conclusion, diverse relapse mechanisms can be observed by systematic reconstruction of cell lineage trees of patients with leukemia.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22645183 DOI: 10.1182/blood-2011-10-388629
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113